28 December 2023
Over 85% of female lung cancer patients in Asia never smoked, compared to 15% in the West. Genetic mutations are far higher in Asia. Initial cost-benefit analysis suggests Asian countries may gain US$40 million by screening the high-risk for lung cancer.